4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-25-045393
Chief Accounting Officer sold 2,347 shares at $6.74 ($15,819)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Liao Carrie Chief Accounting Officer | 2025-03-25 | Sale 10b5-1 | −2,347 | $6.74 | $15,819 | 144,923 | D |
| Open-market sales · 2,347 sh · avg $6.74 · $15,819 | |||||||
Loading xslF345X05/ownership.xml…